New! Sign up for our free email newsletter.
Science News
from research organizations

Lymphomas tied to metabolic disruption

Evidence of enzyme deficiency found in these often-fatal cancers

Date:
July 17, 2015
Source:
University of Texas Health Science Center at San Antonio
Summary:
Direct links between disrupted metabolism and an often fatal type of lymphoma have been uncovered by researchers.
Share:
FULL STORY

Researchers from the School of Medicine at The University of Texas Health Science Center at San Antonio have found evidence that directly links disrupted metabolism (energy production in cells) to a common and often fatal type of lymphoma. The finding was announced in Nature Communications.

"The link between metabolism and cancer has been proposed or inferred to exist for a long time, but what is more scarce is evidence for a direct connection -- genetic mutations in metabolic enzymes," said senior author Ricardo C.T. Aguiar, M.D., Ph.D., associate professor of hematology-oncology in the School of Medicine and a faculty scientist with the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center and the South Texas Veterans Health Care System, Audie L. Murphy Division.

"We have discovered a metabolic imbalance that is oncogenic or pro-cancer," Dr. Aguiar said.

The team, which included members of the Health Science Center departments of medicine and biochemistry, investigators from the UT Southwestern Medical Center at Dallas and a group of collaborators from Austria, found that the gene that codes the enzyme D2-hydroxyglutarate dehydrogenase (D2HGDH) is mutated in a subset of cancers called diffuse large B-cell lymphomas. The mutated lymphoma cell displays a deficiency of a metabolite called alpha-ketoglutarate (α-KG), which is needed in steady levels for cells to be healthy.

"When the levels of α-KG are abnormally low, another class of enzymes called dioxygenases don't function properly, resulting in a host of additional disturbances," Dr. Aguiar said.

Dr. Aguiar indicated that α-KG has been recently identified as a critical regulator of aging and stem cell maintenance. "Thus, the implications of our findings are broad and not limited to cancer biology," he said.


Story Source:

Materials provided by University of Texas Health Science Center at San Antonio. Note: Content may be edited for style and length.


Journal Reference:

  1. An-Ping Lin, Saman Abbas, Sang-Woo Kim, Manoela Ortega, Hakim Bouamar, Yissela Escobedo, Prakash Varadarajan, Yuejuan Qin, Jessica Sudderth, Eduard Schulz, Alexander Deutsch, Sumitra Mohan, Peter Ulz, Peter Neumeister, Dinesh Rakheja, Xiaoli Gao, Andrew Hinck, Susan T. Weintraub, Ralph J. DeBerardinis, Heinz Sill, Patricia L. M. Dahia, Ricardo C. T. Aguiar. D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2. Nature Communications, 2015; 6: 7768 DOI: 10.1038/ncomms8768

Cite This Page:

University of Texas Health Science Center at San Antonio. "Lymphomas tied to metabolic disruption." ScienceDaily. ScienceDaily, 17 July 2015. <www.sciencedaily.com/releases/2015/07/150717142435.htm>.
University of Texas Health Science Center at San Antonio. (2015, July 17). Lymphomas tied to metabolic disruption. ScienceDaily. Retrieved June 15, 2024 from www.sciencedaily.com/releases/2015/07/150717142435.htm
University of Texas Health Science Center at San Antonio. "Lymphomas tied to metabolic disruption." ScienceDaily. www.sciencedaily.com/releases/2015/07/150717142435.htm (accessed June 15, 2024).

Explore More

from ScienceDaily

RELATED STORIES